Correlation Between Qualigen Therapeutics and Ilika Plc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Ilika Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Ilika Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Ilika plc, you can compare the effects of market volatilities on Qualigen Therapeutics and Ilika Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Ilika Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Ilika Plc.

Diversification Opportunities for Qualigen Therapeutics and Ilika Plc

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Qualigen and Ilika is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Ilika plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ilika plc and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Ilika Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ilika plc has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Ilika Plc go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and Ilika Plc

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Ilika Plc. In addition to that, Qualigen Therapeutics is 1.64 times more volatile than Ilika plc. It trades about -0.05 of its total potential returns per unit of risk. Ilika plc is currently generating about -0.01 per unit of volatility. If you would invest  49.00  in Ilika plc on September 12, 2024 and sell it today you would lose (22.00) from holding Ilika plc or give up 44.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy99.7%
ValuesDaily Returns

Qualigen Therapeutics  vs.  Ilika plc

 Performance 
       Timeline  
Qualigen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Ilika plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ilika plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward-looking signals remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Qualigen Therapeutics and Ilika Plc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qualigen Therapeutics and Ilika Plc

The main advantage of trading using opposite Qualigen Therapeutics and Ilika Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Ilika Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ilika Plc will offset losses from the drop in Ilika Plc's long position.
The idea behind Qualigen Therapeutics and Ilika plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Directory
Find actively traded commodities issued by global exchanges